Related Experiment Video

Updated: May 24, 2026

Production of High-Titer Recombinant Newcastle Disease Virus from Allantoic Fluid
07:24

Production of High-Titer Recombinant Newcastle Disease Virus from Allantoic Fluid

Published on: May 25, 2022

Oncolytic Newcastle disease virus for cancer therapy: old challenges and new directions

Dmitriy Zamarin1, Peter Palese

  • 1Department of Microbiology, Mount Sinai School of Medicine, New York, NY 10029, USA. zamarind@mskcc.org

Future Microbiology
|March 8, 2012
PubMed

Insights

Newcastle disease virus (NDV) shows promise as an oncolytic virus therapy for cancer. Research is exploring NDV

Area of Science:

  • Oncology
  • Virology
  • Biotechnology

Background:

  • Newcastle disease virus (NDV) is an avian paramyxovirus.
  • NDV exhibits significant oncolytic activity against various mammalian cancers.
  • Understanding NDV's mechanisms against cancer is crucial for therapeutic development.

Purpose of the Study:

  • To review the mechanisms of NDV-mediated oncolysis.
  • To discuss the development of genetically engineered oncolytic agents based on NDV.
  • To highlight the potential of NDV in cancer treatment strategies.

Main Methods:

  • Literature review of existing research on NDV and cancer.
  • Analysis of studies detailing NDV's oncolytic mechanisms.
  • Examination of genetic engineering approaches for NDV-based therapies.

Main Results:

  • NDV demonstrates potent oncolytic effects on cancer cells.
  • Genetic engineering can enhance NDV's efficacy and specificity.
  • Clinical trials are underway to evaluate NDV strains and vaccines.

Conclusions:

  • NDV is a promising oncolytic virus for cancer therapy.
  • Further clinical evaluation of NDV-based strategies is warranted.
  • NDV holds potential for successful clinical application in oncology.

More Related Videos

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo12:42

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Published on: January 7, 2019

Ex Vivo Infection of Live Tissue with Oncolytic Viruses12:08

Ex Vivo Infection of Live Tissue with Oncolytic Viruses

Published on: June 25, 2011

Related Concept Videos

Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Mechanisms of Retrovirus-induced Cancers01:51

Mechanisms of Retrovirus-induced Cancers

Retroviruses are RNA viruses that have been shown to cause cancers in diverse species, including chickens, mice, cats, and monkeys. The RNA genomes of these viruses are first reverse-transcribed into single and then double-stranded DNA (dsDNA) copies. This dsDNA called proviral DNA then integrates into the host genome. Subsequently, the host cell transcribes the proviral DNA in concert with the chromosomal DNA. This leads to the production of viral RNA and proteins that assemble at the host...
Mechanisms of Retrovirus-induced Cancers01:51

Mechanisms of Retrovirus-induced Cancers

Retroviruses are RNA viruses that have been shown to cause cancers in diverse species, including chickens, mice, cats, and monkeys. The RNA genomes of these viruses are first reverse-transcribed into single and then double-stranded DNA (dsDNA) copies. This dsDNA called proviral DNA then integrates into the host genome. Subsequently, the host cell transcribes the proviral DNA in concert with the chromosomal DNA. This leads to the production of viral RNA and proteins that assemble at the host...
Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Treatment Resistent Cancers02:56

Treatment Resistent Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...